Sculptor Capital LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2018$410,000
-33.0%
43,400
+42.8%
0.00%
-50.0%
Q3 2018$612,00030,4000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN 240,000$1,116,00099.38%
TANG CAPITAL MANAGEMENT LLC 9,607,934$44,677,0008.98%
HealthInvest Partners AB 830,000$3,860,0005.44%
RTW INVESTMENTS, LP 2,327,903$10,825,0000.16%
GLOBEFLEX CAPITAL L P 185,598$864,0000.09%
WealthTrust Axiom LLC 25,400$118,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 82,355$383,0000.03%
FIRST MIDWEST BANK TRUST DIVISION 41,731$194,0000.02%
ACADIAN ASSET MANAGEMENT LLC 435,387$2,023,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 17,176$80,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders